Abstracts - faqs.org

Abstracts

Science and technology

Search abstracts:
Abstracts » Science and technology

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

Article Abstract:

Amyloid beta protein (ABP) is a small protein which is the major component of the brain deposits that occur in Alzheimer's disease and Down syndrome. Although its structure and chemistry have been characterized, the role of ABP in normal biological function and in the development of Alzheimer's disease are unknown. Studies have suggested two opposite effects of ABP. One showed that a protein containing ABP was toxic to nerve cells grown in the laboratory, while the other showed that a protein structurally similar to ABP increased the survival of similar nerve cells. This study shows that ABP has both of these effects, neurotoxic and neurotrophic, depending on the age of the nerve cells and the dose of ABP. Low doses of ABP improved survival of immature cells, which have few characteristics of adult nerve cells. However, high levels of ABP were toxic to adult cells, which have differentiated, and the doses caused loss of nerve cell branches before cell death. The same small segment of the ABP protein was responsible for both of these effects. In addition, tachykinins, another group of nerve proteins, had similar activity. Tachykinin blockers mimicked ABP effects, which were reversed by the tachykinins. The study provides evidence for a functional role of ABP, and suggests that accumulation of high doses of ABP in the adult brain, as occurs in Alzheimer's disease, may lead to degeneration of nerves. The effects of tachykinins in reversing these effects may have significance in treatment strategies for Alzheimer's disease. (Consumer Summary produced by Reliance Medical Information, Inc.)

Author: Yankner, Bruce A., Duffy, Lawrence K., Kirschner, Daniel A.
Publisher: American Association for the Advancement of Science
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1990
Alzheimer's disease, Tachykinins

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


GTP hydrolysis in protein synthesis: two for Tu?

Article Abstract:

Researchers have used a new method to determine that the energy needed for protein synthesis is greater than the amount that most textbooks report. Evidence suggests that the stoichiometry of hydrolysis of GTP is greater than two.

Author: Schimmel, Paul
Publisher: American Association for the Advancement of Science
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1993
Proteins, Protein synthesis, Stoichiometry

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Neuropeptides, adenylyl cyclase, and memory storage

Article Abstract:

Research on the cloned Drosophila memory gene amnesiac is providing insights into the role of neuropeptides in memory storage. Amnesiac encodes a peptide that is similar to mammalian adenylyl cyclase activating peptide.

Author: Kandel, Eric, Abel, Ted
Publisher: American Association for the Advancement of Science
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1995
Genetic aspects, Memory, Drosophila, Adenylate cyclase

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Physiological aspects, Neuropeptides, Research
Similar abstracts:
  • Abstracts: Synthesis and properties of cyclopropane-derived peptidomimetics. Photophysics and photochemistry of pterins in aqueous solution
  • Abstracts: An economic perspective on outdoor residential pesticide use. Pesticides in streams draining agricultural and urban areas in Colorado
  • Abstracts: Neurobiology: gene discovery offers tentative clues to Parkinson's
  • Abstracts: The adoption and diffusion of environmentally friendly technologies among firms. Development and innovation in the Japanese chemical industry
  • Abstracts: Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor. Shared human T cell receptor V-beta usage to immunodominant regions of myelin basic protein
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.